583 related articles for article (PubMed ID: 31678092)
21. Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan.
Machida H; Matsuo K; Furusawa A; Kita T; Kitagawa R; Mikami M
PLoS One; 2019; 14(1):e0210125. PubMed ID: 30615679
[TBL] [Abstract][Full Text] [Related]
22. Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer.
Shin JY; Yoon JK; Marwaha G
Lung; 2018 Jun; 196(3):351-358. PubMed ID: 29550987
[TBL] [Abstract][Full Text] [Related]
23. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
[TBL] [Abstract][Full Text] [Related]
24. Completing or Abandoning Radical Hysterectomy in Early-Stage Lymph Node-Positive Cervical Cancer: Impact on Disease-Free Survival and Treatment-Related Toxicity.
Derks M; Groenman FA; van Lonkhuijzen LRCW; Schut PC; Westerveld H; van der Velden J; Kenter GG
Int J Gynecol Cancer; 2017 Jun; 27(5):1015-1020. PubMed ID: 28498252
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
27. A Scoring System to Select the Candidates for Adjuvant Chemotherapy Alone in High-Risk Early-Stage Cervical Cancer Patients With Pelvic Lymph Node Metastases After Surgery.
Yang XL; Yang FL; Wang N; Zhang YE; Kou LN; Wu DJ; Luo Y
Am J Clin Oncol; 2023 May; 46(5):219-224. PubMed ID: 36877193
[TBL] [Abstract][Full Text] [Related]
28. Association between definitive chemoradiotherapy wait-time and survival in locally-advanced cervical cancer: Implications during the coronavirus pandemic.
Matsuo K; Huang Y; Matsuzaki S; Ragab OM; Roman LD; Wright JD
Gynecol Oncol; 2021 May; 161(2):414-421. PubMed ID: 33771396
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
Park SH; Cheon H; Chong GO; Jeong SY; Lee JE; Kang MK; Kim MY; Lee JW; Park J; Kim JC
Gynecol Oncol; 2018 Mar; 148(3):449-455. PubMed ID: 29329882
[TBL] [Abstract][Full Text] [Related]
30. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
[TBL] [Abstract][Full Text] [Related]
31. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
Kornovski Y; Gorchev G
J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
[TBL] [Abstract][Full Text] [Related]
32. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
[TBL] [Abstract][Full Text] [Related]
33. Postoperative adjuvant therapy in early invasive cervical cancer patients with histopathologic high-risk factors.
Park TK; Kim SN; Kwon JY; Mo HJ
Int J Gynecol Cancer; 2001; 11(6):475-82. PubMed ID: 11906552
[TBL] [Abstract][Full Text] [Related]
34. Effects of preoperative radiotherapy or chemoradiotherapy on postoperative pathological outcome of cervical cancer--from the large database of 46,313 cases of cervical cancer in China.
Li W; Liu P; Zhao W; Yin Z; Lin Z; Bin X; Lang J; Chen C
Eur J Surg Oncol; 2020 Jan; 46(1):148-154. PubMed ID: 31623897
[TBL] [Abstract][Full Text] [Related]
35. Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer.
Matsuo K; Machida H; Horowitz MP; Shahzad MMK; Guntupalli SR; Roman LD; Wright JD
Am J Obstet Gynecol; 2017 Nov; 217(5):580.e1-580.e10. PubMed ID: 28666700
[TBL] [Abstract][Full Text] [Related]
36. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
37. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
38. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
Bean LM; Ward KK; Plaxe SC; McHale MT
Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
[TBL] [Abstract][Full Text] [Related]
39. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer.
Matsuo K; Machida H; Shoupe D; Melamed A; Muderspach LI; Roman LD; Wright JD
Obstet Gynecol; 2017 Jan; 129(1):139-151. PubMed ID: 27926642
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]